National Heart, Lung, and Blood Institute; Notice of Meeting, 73794-73795 [2021-28087]
Download as PDF
<![CDATA[
73794
Federal Register / Vol. 86, No. 246 / Tuesday, December 28, 2021 / Notices
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: December 21, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
National Institutes of Health
National Institute on Aging; Notice of
Closed Meetings
National Heart, Lung, and Blood
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
[FR Doc. 2021–28088 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Aging; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
Name of Committee: National Institute on
Aging Special Emphasis Panel; Data Analyses
for the Better Understanding of Long-Term
Osteoporosis Therapy.
Date: March 2, 2022.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Joshua Jin-Hyouk Park,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway
Building 2W200, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (301) 496–6208,
joshua.park4@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28099 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute on
Aging Special Emphasis Panel; Gene Delivery
System for AD/ADRD Therapy Development.
Date: January 28, 2022.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Video Meeting).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, 301–480–1266, neuhuber@
ninds.nih.gov.
Name of Committee: National Institute on
Aging Special Emphasis Panel; MechanismBased Adult Stem Cell Treatments to Combat
Aging.
Date: February 11, 2022.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892, (Video Meeting).
Contact Person: Birgit Neuhuber, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, 301–480–1266, neuhuber@
ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28100 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
22:45 Dec 27, 2021
Jkt 256001
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Name of Committee: Sickle Cell Disease
Advisory Committee.
Date: January 25, 2022.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: Presentations and discussion of
programs.
Place: National Institutes of Health,
Rockledge II, 6705 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Telephone Access: 1–646–828–7666
(Meeting ID: 160 241 4559) Passcode: 076579.
Virtual Access: https://nih.zoomgov.com
(Meeting ID: 160 241 4559) Passcode: 076579.
Contact Person: W. Keith Hoots, MD.,
Director, Division of Blood Diseases and
Resources, National Heart, Lung, and Blood
Institute, 6705 Rockledge Drive, Bethesda,
MD 20892, 301–435–0080, hootswk@
nhlbi.nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meeting. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
Information is also available on the
Institute’s/Center’s home page:
www.nhlbi.nih.gov/meetings/index.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
E:\FR\FM\28DEN1.SGM
28DEN1
Federal Register / Vol. 86, No. 246 / Tuesday, December 28, 2021 / Notices
and Resources Research, National Institutes
of Health, HHS)
Dated: December 21, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28087 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
(Catalogue of Federal Domestic Assistance
Program Nos. 93.866, Aging Research,
National Institutes of Health, HHS)
Dated: December 21, 2021.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
National Institute on Aging; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
khammond on DSKJM1Z7X2PROD with NOTICES
[FR Doc. 2021–28151 Filed 12–27–21; 8:45 am]
BILLING CODE 4140–01–P
Name of Committee: National Institute on
Aging Initial Review Group; Career
Development Facilitating the Transition to
Independence Study Section.
Date: January 31–February 1, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Nijaguna Prasad, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Institute on Aging, National
Institutes of Health, 7201 Wisconsin Avenue,
Gateway Building, Suite 2W200, Bethesda,
MD 20892, 301–496–9667, nijaguna.prasad@
nih.gov.
Name of Committee: National Institute on
Aging Initial Review Group; Career
Development for Early Career Investigators
Study Section.
Date: January 31–February 1, 2022.
Time: 10:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute on Aging,
Gateway Building, 7201 Wisconsin Avenue,
Bethesda, MD 20892 (Video Meeting).
Contact Person: Carmen Moten, Ph.D.,
MPH, Scientific Review Officer, Scientific
Review Branch, National Institute on Aging,
National Institutes of Health, Gateway Bldg.,
2C212, 7201 Wisconsin Avenue, Bethesda,
MD 20814, 301–402–7703, cmoten@
mail.nih.gov.
Jkt 256001
DEPARTMENT OF HOMELAND
SECURITY
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
22:45 Dec 27, 2021
Dated: December 21, 2021.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–28098 Filed 12–27–21; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
73795
National Institutes of Health
Notice of the Critical Infrastructure
Partnership Advisory Council
Cybersecurity and
Infrastructure Security Agency (CISA),
Department of Homeland Security
(DHS).
AGENCY:
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel; Large
Scale Mapping and/or Molecular Profiling of
Ensembles and/or Cell-Types Mediating
Opioid Action in the Rodent Brain (R01—
Clinical Trial Not Allowed).
Date: February 17, 2022.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
National Institute on Drug Abuse, 301
Northstone Street Avenue, Bethesda, MD
20892 (Virtual Meeting).
Contact Person: Soyoun Cho, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, Division of Extramural Research,
National Institute on Drug Abuse, NIH, 301
North Stonestreet Avenue, Bethesda, MD
20892, (301) 594–9460, Soyoun.cho@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.277, Drug Abuse Scientist
Development Award for Clinicians, Scientist
Development Awards, and Research Scientist
Awards; 93.278, Drug Abuse National
Research Service Awards for Research
Training; 93.279, Drug Abuse and Addiction
Research Programs, National Institutes of
Health, HHS)
PO 00000
Notice of availability; Critical
Infrastructure Partnership Advisory
Council membership update.
ACTION:
On November 30, 2021, the
Department updated the Critical
Infrastructure Partnership Advisory
Council (CIPAC) Membership. Through
this notice, the Department is making
the updated CIPAC Membership Rosters
publicly available on the CIPAC
website.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Ginger K. Norris, 202–441–5885,
CIPAC@cisa.dhs.gov.
DHS
established the CIPAC on March 24,
2006. (71 FR 14930). The CIPAC
facilitates interactions between
government officials and representatives
of owners and/or operators for each of
the critical infrastructure sectors
designated in Presidential Policy
Directive 21 and identified in the
current National Infrastructure
Protection Plan. Pursuant to section
V.C.5 of the CIPAC Charter, the CIPAC
Executive Secretariat is required to
maintain a membership list on the
publicly-available CIPAC website and
publish annual updates to announce
changes in CIPAC membership. Please
visit https://www.cisa.gov/criticalinfrastructure-partnership-advisorycouncil for more information on CIPAC
and to view the CIPAC Membership
Rosters.
SUPPLEMENTARY INFORMATION:
Ginger K. Norris,
Designated Federal Official, Critical
Infrastructure Partnership Advisory Council,
Cybersecurity and Infrastructure Security
Agency, Department of Homeland Security.
[FR Doc. 2021–28177 Filed 12–27–21; 8:45 am]
BILLING CODE 9110–9P–P
Frm 00076
Fmt 4703
Sfmt 4703
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 86, Number 246 (Tuesday, December 28, 2021)]
[Notices]
[Pages 73794-73795]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-28087]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Sickle Cell Disease
Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Sickle Cell Disease Advisory Committee.
Date: January 25, 2022.
Time: 10:00 a.m. to 1:30 p.m.
Agenda: Presentations and discussion of programs.
Place: National Institutes of Health, Rockledge II, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Telephone Access: 1-646-828-7666 (Meeting ID: 160 241 4559)
Passcode: 076579.
Virtual Access: https://nih.zoomgov.com (Meeting ID: 160 241
4559) Passcode: 076579.
Contact Person: W. Keith Hoots, MD., Director, Division of Blood
Diseases and Resources, National Heart, Lung, and Blood Institute,
6705 Rockledge Drive, Bethesda, MD 20892, 301-435-0080,
[email protected].
Any member of the public interested in presenting oral comments
to the committee may notify the Contact Person listed on this notice
at least 10 days in advance of the meeting. Interested individuals
and representatives of organizations may submit a letter of intent,
a brief description of the organization represented, and a short
description of the oral presentation. Only one representative of an
organization may be allowed to present oral comments and if accepted
by the committee, presentations may be limited to five minutes. Both
printed and electronic copies are requested for the record. In
addition, any interested person may file written comments with the
committee by forwarding their statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: www.nhlbi.nih.gov/meetings/index.htm, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases
[[Page 73795]]
and Resources Research, National Institutes of Health, HHS)
Dated: December 21, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-28087 Filed 12-27-21; 8:45 am]
BILLING CODE 4140-01-P
